A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature
DOI 10.1038/243290a0

Cited by (1,005)

Items 401–500 of 1,005

  1. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.
    Anne‐Marie Mes‐Masson, Jami McLaughlin, G Q Daley, Michael P. Paskind, Owen N. Witte · 1986 · Proceedings of the National Academy of Sciences
  2. The Bcl-2 gene family and apoptosis
    Elizabeth M. Bruckheimer, S. H. Cho, Mona G. Sarkiss, John L. Herrmann, Timothy J. McDonnell · 1998 · Advances in biochemical engineering, biotechnology
  3. The Role of Mechanistic Factors in Promoting Chromosomal Translocations Found in Lymphoid and Other Cancers
    Yu Zhang, Monica Gostissa, Dominic G. Hildebrand, Michael S. Becker, Cristian Boboilă, Roberto Chiarle, Susanna M. Lewis, Frederick W. Alt · 2010 · Advances in immunology
  4. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
    G. Vignir Helgason, Maria Karvela, Tessa L. Holyoake · 2011 · Blood
  5. Clinical Utility of Contemporary Molecular Cytogenetics
    Bassem A. Bejjani, Lisa G. Shaffer · 2008 · Annual Review of Genomics and Human Genetics
  6. Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.
    Jun‐ichi Azumi, Leo Sachs · 1977 · Proceedings of the National Academy of Sciences
  7. Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions
    Brian J.P. Huntly · 2003 · Blood
  8. Genesis of the 14q+ marker in Burkitt's lymphoma
    Yanka Manolova, George Manolov, J. Kieler, ALBERT LEVAN, George Klein · 2009 · Hereditas
  9. The Hypereosinophilic Syndrome: Clinical Features, Laboratory Findings and Treatment
    Christopher J. F. Spry · 1982 · Allergy
  10. Cancer genetics: from Boveri and Mendel to microarrays
    Allan Balmain · 2001 · Nature reviews. Cancer
  11. Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis
    Christine Beham‐Schmid, Ute Apfelbeck, Heinz Sill, Oleksiy Tsybrovsky, Gerald Höfler, Oskar A. Haas, Werner Linkesch · 2002 · Blood
  12. Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
    Theresa Liu Dumlao, Hagop M. Kantarjian, Deborah Ann Thomas, Susan Mary O'Brien, Farhad Ravandi · 2012 · Current Oncology Reports
  13. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia
    A Bedi, BA Zehnbauer, Michael I. Collector, James P. Barber, Milada S. Zicha, Saul J. Sharkis, RJ Jones · 1993 · Blood
  14. Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia
    Brian J.P. Huntly, Anthony J. Bench, Anthony Richard Green · 2003 · Blood
  15. European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia
    Cross, Nicholas C. P., Ernst, Thomas, Branford, Susan, Cayuela, Jean-Michel, Deininger, Michael, Fabarius, Alice, Kim, Dennis Dong Hwan, Machova Polakova, Katerina, Radich, Jerald P., Hehlmann, Rüdiger et al. · 2023 · Leukemia
  16. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line
    Qi Zhao, Otávia L. Caballero, Samuel Levy, Brian J. Stevenson, Christian Iseli, SANDRO JOSÉ DE SOUZA, Pedro A. F. Galante, Dana Busam, Margaret A. Leversha, Kalyani Chadalavada et al. · 2009 · Proceedings of the National Academy of Sciences
  17. Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
    Simona Luatti, Fausto Castagnetti, Giulia Marzocchi, Carmen Baldazzi, Gabriele Gugliotta, Ilaria Iacobucci, Giorgina Specchia, Lucia Zanatta, Giovanna Rege‐Cambrin, Marco Mancini et al. · 2012 · Blood
  18. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
    Giulia Marzocchi, Fausto Castagnetti, Simona Luatti, Carmen Baldazzi, Monica Stacchini, Gabriele Gugliotta, Marilina Amabile, Giorgina Specchia, Mario Sessarego, Ursula Giussani et al. · 2011 · Blood
  19. Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
    Alberto Maria Martelli, Francesca Chiarini, Camilla Evangelisti, Alessandra Cappellini, Francesca Buontempo, Daniela Bressanin, Milena Fini, James Andrew McCubrey · 2012 · Oncotarget
  20. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
    Chang-Hoon Nam, T. Rabbitts · 2006 · Molecular Therapy
  21. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature
    Yi‐Kong Keung, Michael W. Beaty, Bayard L. Powell, István Molnár, David Buss, Mark J. Pettenati · 2004 · Leukemia Research
  22. Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
    Robin Foà, Sabina Chiaretti · 2022 · New England Journal of Medicine
  23. Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
    Michael E O'Dwyer, Michael J. Mauro, Carolyn Blasdel, M Farnsworth, Gwen Kurilik, Yi‐Ching Hsieh, Motomi Mori, Brian J. Druker · 2003 · Blood
  24. Applying the discovery of the Philadelphia chromosome
    Daniel W. Sherbenou, Brian J. Druker · 2007 · Journal of Clinical Investigation
  25. Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL–Positive Cells
    Douglas J. Kominsky, Jost Klawitter, Jaimi L. Brown, László G. Boros, Junia V. Melo, S. Gail Eckhardt, Natalie Julie Serkova · 2009 · Clinical Cancer Research
  26. Genetics and Etiology of Human Cancer
    Alfred G. Knudson · 1977 · Springer eBooks
  27. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction
    MS Lee, Anne LeMaistre, HM Kantarjian, Moshe Talpaz, EJ Freireich, JM Trujillo, Sanford A. Stass · 1989 · Blood
  28. Insights into the stem cells of chronic myeloid leukemia
    I. Sloma, Xiao-Yan Jiang, A. Eaves, C. Eaves · 2010 · Leukemia
  29. BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors
    Mhairi Copland, Francesca Pellicano, Linda Richmond, Elaine K. Allan, Ashley Hamilton, Francis Y. Lee, Roberto Simon Weinmann, Tessa L. Holyoake · 2007 · Blood
  30. Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
    Christoph Walz, Martin Sattler · 2005 · Critical Reviews in Oncology/Hematology
  31. TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS
    Raoul Tibes, Jonathan C. Trent, Razelle Kurzrock · 2004 · The Annual Review of Pharmacology and Toxicology
  32. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14.
    Norio Wake, Myroslaw M. Hreshchyshyn, Steven M. Piver, Seiichi Matsui, Avery A. Sandberg · 1980 · PubMed
  33. Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
    Brittany C. Parker, Manon Engels, Matti Annala, Wei Zhang · 2013 · The Journal of Pathology
  34. STAT Signaling in the Pathogenesis and Treatment of Cancer
    David A. Frank · 1999 · Molecular Medicine
  35. Aneuploidy Precedes and Segregates with Chemical Carcinogenesis
    PETER H. DUESBERG, Ruhong Li, David Rasnick, Charlotte Rausch, Andreas Willer, Alwin Kraemer, George Yerganian, Rüediger Hehlmann · 2000 · Cancer Genetics and Cytogenetics
  36. Blast crisis in a murine model of chronic myelogenous leukemia.
    George Q. Daley, Richard A. Van Etten, David Baltimore · 1991 · Proceedings of the National Academy of Sciences
  37. Xiphophorus As An In Vivo Model for Studies on Normal and Defective Control of Oncogenes
    Fritz Anders, Manfred Schartl, Angelika Barnekow, Annerose Anders · 1984 · Advances in cancer research
  38. Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types
    Craig P. Giacomini, Steven Sun, Sushama Varma, Alan Hunter Shain, Marilyn M. Giacomini, Jay Michael S. Balagtas, Robert T. Sweeney, Everett Lai, Catherine Del Vecchio Fitz, Andrew D. Forster et al. · 2013 · PLoS Genetics
  39. Neural regulation of bone and bone marrow
    Maryanovich, Maria, Takeishi, Shoichiro, Frenette, Paul S. · 2018 · Cold Spring Harbor Perspectives in Medicine
  40. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate
    Michael E O'Dwyer, Ken M. Gatter, Marc Loriaux, Brian J. Druker, Susan B. Olson, R.E. Magenis, Helen J. Lawce, Michael J. Mauro, Richard Thomas Maziarz, Rita M. Braziel · 2003 · Leukemia
  41. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction
    MS Lee, KS Chang, EJ Freireich, HM Kantarjian, Moshe Talpaz, JM Trujillo, Sanford A. Stass · 1988 · Blood
  42. Interstitial deletion of short arm of chromosome 11 limited to Wilms' tumor cells in a patient without aniridia.
    Yasuhiko Kaneko, M C Egues, J D Rowley · 1981 · PubMed
  43. The Impact of Next-Generation Sequencing on Cancer Genomics: From Discovery to Clinic
    Elaine R. Mardis · 2018 · Cold Spring Harbor Perspectives in Medicine
  44. Philadelphia chromosome‐positive acute lymphoblastic leukemia
    Hun Ju Lee, James E. Thompson, Eunice S. Wang, Meir Wetzler · 2010 · Cancer
  45. ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
    Maria Karvela, Pablo Baquero, Elodie M. Kuntz, Arunima Mukhopadhyay, Rebecca Mitchell, Elaine K. Allan, Edmond Y.W. Chan, Kamil R. Kranc, Bruno Calabretta, Paolo Salomoni et al. · 2016 · Autophagy
  46. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array
    Steven S. Shen, Peter S. Zhang, Omar E. Eton, Victor Gerardo Prieto · 2003 · Journal of Cutaneous Pathology
  47. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
    B Clarkson, Annabel Strife, David John Wisniewski, Caryl L Lambek, C Liu · 2003 · Leukemia
  48. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
    Y Honma, Junko Okabe‐Kado, Motoo Hozumi, Y Uehara, Satoshi Mizuno · 1989 · PubMed
  49. Chromosomics: Bridging the Gap between Genomes and Chromosomes
    Janine E. Deakin, Sally Potter, Rachel J. Waugh O'Neill, Aurora Ruiz‐Herrera, Marcelo de Bello Cioffi, Mark D. B. Eldridge, K. Fukui, Jennifer A. Marshall Graves, Darren Karl Griffin, Frank Grützner et al. · 2019 · Genes
  50. Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back
    Nikolas C. C. von Bubnoff, Christian Peschel, Justus Duyster · 2003 · Leukemia
  51. STI-571: an anticancer protein-tyrosine kinase inhibitor
    Robert Jr. Roskoski · 2003 · Biochemical and Biophysical Research Communications
  52. Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
    Martin Sattler, Ravi Salgia · 1997 · Cytokine & Growth Factor Reviews
  53. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia
    Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Moshe Talpaz, Susan Mary O'Brien, Guillermo Garcia‐Manero, Srđan Verstovšek, Mary Beth Rios, Kimberly J. Hayes, Armand B. Glassman, Benjamin Nebiyou Bekele et al. · 2004 · Blood
  54. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
    Karl‐Anton Kreuzer, U Lass, Alexander Bohn, Olfert Landt, C A Schmidt · 1999 · PubMed
  55. BCR/ABL Directly Inhibits Expression of SHIP, an SH2-Containing Polyinositol-5-Phosphatase Involved in the Regulation of Hematopoiesis
    Martin Sattler, Shalini Verma, Christopher H. Byrne, Gautam Shrikhande, Thomas Winkler, Paul A. Algate, Larry R. Rohrschneider, James D. Griffin · 1999 · Molecular and Cellular Biology
  56. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias
    Kaveri Suryanarayan, Stephen P. Hunger, Sabine Köhler, Andrew J. Carroll, WM Crist, MP Link, Michael L. Cleary · 1991 · Blood
  57. CHEWING RELEASES MERCURY FROM FILLINGS
    DonD Gay, RobertD Cox, John W. Reinhardt · 1979 · The Lancet
  58. Pan-cancer analysis of whole genomes
    Peter J. Campbell, Gaddy Getz, Joshua M. Stuart, Jan O. Korbel, Lincoln David Stein · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Important Therapeutic Targets in Chronic Myelogenous Leukemia
    Hagop M. Kantarjian, Francis Joseph Giles, Alfonso Quintás‐Cardama, Jörge E. Cortes · 2007 · Clinical Cancer Research
  60. CHASING THE CANCER DEMON
    Alfred G. Knudson · 2000 · Annual Review of Genetics
  61. CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine
    Ying Gu, Ting Chen, Zhipeng Meng, Yichao Gan, Xiaohua Xu, Guiyu Lou, Hongzhi Li, Xiaoxian Gan, Hong Zhou, Jinfen Tang et al. · 2012 · Blood
  62. Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients
    Koichi Miyamura, T Tahara, Mitsune Tanimoto, Y Morishita, Kohei Kawashima, Yoshiyuki MORISHIMA, Hidehiko Saito, Shinobu Tsuzuki, K Takeyama, Y Kodera · 1993 · Blood
  63. Origin of Chronic Myelocytic Leukemia in a Precursor of Pre-B Lymphocytes
    Tucker W. LeBien, John C. Hozier, Jun Minowada, John H. Kersey · 1979 · New England Journal of Medicine
  64. Leukemia stem cells: the root of chronic myeloid leukemia
    Hong Zhou, Rongzhen Xu · 2015 · Protein & Cell
  65. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
    Carina Heydt, Christina B. Wölwer, Oscar Velázquez Camacho, Svenja Wagener‐Ryczek, Roberto Pappesch, Janna Siemanowski, Jan Rehker, Florian Haller, Abbas Agaimy, Karl Worm et al. · 2021 · BMC Medical Genomics
  66. The story of chronic myeloid leukaemia
    C. G. Geary · 2000 · British Journal of Haematology
  67. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression
    Christian M. Schürch, Carsten Riether, Matthias Sebastian Matter, Alexandar Tzankov, Adrian F. Ochsenbein · 2012 · Journal of Clinical Investigation
  68. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine
    Linping Hu, Kun Ru, Li Zhang, Yu-Ting Huang, Xiaofan Zhu, Hanzhi Liu, Anders Zetterberg, Tao Cheng, Weimin Miao · 2014 · Biomarker Research
  69. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22
    Steven H. Hinrichs, Mary A. Jaramillo, Paul H. Gumerlock, Murray B. Gardner, Jerry P. Lewis, Aaron E. Freeman · 1985 · Cancer Genetics and Cytogenetics
  70. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression
    M.D. Tabernero, Aglae Bortoluci, Irene Alaejos, M C López-Berges, Ana Rasillo, Ramón García‐Sánz, Melissa Garcia, José María Sayagués, Marcos González, Gema Mateo et al. · 2001 · Leukemia
  71. Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced Apoptosis
    Lee Jamieson, Lee Carpenter, Trevor J. Biden, Alan P. Fields · 1999 · Journal of Biological Chemistry
  72. Role of bone marrow matrix in normal and abnormal hematopoiesis
    Catherine M. Verfaillie, Randy Hurley, Ravi Bhatia, James B. McCarthy · 1994 · Critical Reviews in Oncology/Hematology
  73. Molecular cytogenetics: Rosetta stone for understanding cancer--twenty-ninth G. H. A. Clowes memorial award lecture.
    Janet D. Rowley · 1990 · PubMed
  74. Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review
    Ke Yang, Liwu Fu · 2014 · Critical Reviews in Oncology/Hematology
  75. Our changing view of the genomic landscape of cancer
    Daphne W. Bell · 2009 · The Journal of Pathology
  76. Simultaneous Detection of Tumor Cell Apoptosis Regulators Bcl-2 and Bax through a Dual-Signal-Marked Electrochemical Immunosensor
    Shiwei Zhou, Yingying Wang, Jun‐Jie Zhu · 2016 · ACS Applied Materials & Interfaces
  77. Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
    Athena Aktipis, Virginia S. Y. Kwan, Kathryn A. Johnson, Steven L. Neuberg, Carlo C. Maley · 2011 · PLoS ONE
  78. ABL1 fusion genes in hematological malignancies: a review
    Etienne D. Braekeleer, Nathalie Douet‐Guilbert, David W. Rowe, Nick P. Bown, Fréderic Morel, Christian Berthou, Claude Férec, Marc De Braekeleer · 2011 · European Journal Of Haematology
  79. Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents
    Jin Cai, Min Sun, Xiaoqing Wu, Junqing Chen, Peng Wang, Xi Zong, Min Ji · 2013 · European Journal of Medicinal Chemistry
  80. Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia
    David J. Barnes, Junia V. Melo · 2002 · Acta Haematologica
  81. Improved Sensitivity of BCR-ABL Detection: A Triple-Probe Three-Color Fluorescence In Situ Hybridization System
    Paul B Sinclair, A.R. Green, Colin D. Grace, Elisabeth P. Nacheva · 1997 · Blood
  82. Intergenically Spliced Chimeric RNAs in Cancer
    Yuemeng Jia, Zhongqiu Xie, Hui Li · 2016 · Trends in cancer
  83. Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization
    Sabine Naumann, Dirk Reutzel, Michael R. Speicher, Hans-Jochen Decker · 2001 · Leukemia Research
  84. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL
    Marilyn Pearson, James W. Vardiman, Michelle M. Le Beau, Janet D. Rowley, Stuart Schwartz, Shelly L. Kerman, Maimon M. Cohen, Elena W. Fleischman, Elena L. Prigogina · 1985 · American Journal of Hematology
  85. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
    Chiara Corrado, Laura Saieva, Stefania Raimondo, Alessandra Santoro, Giacomo De Leo, Riccardo Alessandro · 2016 · Journal of Cellular and Molecular Medicine
  86. Treatment for chronic myelogenous leukemia: the long road to imatinib
    Tony R. Hunter · 2007 · Journal of Clinical Investigation
  87. Chromosome changes in 17 human neoplasms studied with banding
    Margaret F. Der Van Riet-Fox, Andries E. Retief, W. A. Van Niekerk · 1979 · Cancer
  88. RUNX1 Mutations in Clonal Myeloid Disorders: From Conventional Cytogenetics to Next Generation Sequencing, A Story 40 Years in the Making
    James K. Mangan, Nancy A. Speck · 2011 · Critical Reviews™ in Oncogenesis
  89. Genomics and proteomics in cancer
    Jan P. A. Baak, F.R.C. Path, Mario A. J. A. Hermsen, Gerrit A. Meijer, Johannes A. Schmid, Emiel A. M. Janssen · 2003 · European Journal of Cancer
  90. Bcr-Abl inhibition as a modality of CML therapeutics
    Elisabeth Buchdunger, Alex Matter, Brian J. Druker · 2001 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  91. Karyotypic progression in human tumors
    Sandra R. Wolman · 1983 · Cancer and Metastasis Reviews
  92. Detection and quantification of residual disease in chronic myelogenous leukemia
    Andreas Hochhaus, Andreas Weisser, Paul Graf La Rosée, Michael Emig, M. C. Muller, Susanne Saußele, Andreas Reiter, Christian Kühn, Ute Berger, R. Hehlmann et al. · 2000 · Leukemia
  93. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria
    Martha Wadleigh, Ayalew Tefferi · 2010 · International Journal of Hematology
  94. A Short History of Chromosome Rearrangements and Gene Fusions in Cancer
    Felix Mitelman · 2015 · Springer eBooks
  95. Development of protein degradation inducers of oncogenic BCR ‐ ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
    Norihito Shibata, Naoki Miyamoto, Katsunori Nagai, Kenichiro Shimokawa, Tomoya Sameshima, Nobumichi Ohoka, Takayuki Hattori, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho et al. · 2017 · Cancer Science
  96. BCR Rearrangement–Negative Chronic Myelogenous Leukemia Revisited
    Razelle Kurzrock, Carlos Bueso-Ramos, Hagop M. Kantarjian, Emil J. Freireich, Susan L. Tucker, Michael J. Siciliano, Susan R. Pilat, Moshe Talpaz · 2001 · Journal of Clinical Oncology
  97. Mutator phenotype of BCR – ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase β
    Yvan Canitrot, Dominique Lautier, Guy Laurent, Mathilde Fréchet, Aqila A. Ahmed, Ali G. Turhan, Bernard Salles, Christophe Cazaux, Jean‐Sébastien Hoffmann · 1999 · Oncogene
  98. Signal transduction by wild-type and leukemogenic Abl proteins
    Arthur B. Raitano, Young E. Whang, Charles L. Sawyers · 1997 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  99. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia
    Robert Delage, Robert J. Soiffer, Keith B. G. Dear, Jerome Ritz · 1991 · Blood
  100. CML patients in blast crisis have breakpoints localized to a specific region of the BCR
    K E Schaefer-Rego, H Dudek, DW Popenoe, Z. A. Arlin, JG Mears, A Bank, David S. Leibowitz · 1987 · Blood